Procaps Group S.A. (NASDAQ:PROC – Get Free Report) shares dropped 40.3% during trading on Friday . The stock traded as low as $0.77 and last traded at $0.95. Approximately 658,169 shares traded hands during trading, an increase of 1,594% from the average daily volume of 38,864 shares. The stock had previously closed at $1.59.
Procaps Group Stock Performance
The firm has a 50-day moving average price of $1.24 and a 200 day moving average price of $1.68.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Procaps Group stock. Itau Unibanco Holding S.A. bought a new stake in Procaps Group S.A. (NASDAQ:PROC – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned 0.16% of Procaps Group at the end of the most recent quarter.
Procaps Group Company Profile
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Featured Articles
- Five stocks we like better than Procaps Group
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- How to Build the Ultimate Everything ETF Portfolio
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Stock Splits, Do They Really Impact Investors?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
